The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study

被引:12
|
作者
Shafer, Leigh Anne [1 ,2 ]
Nsubuga, Rebecca N. [2 ]
Chapman, Ruth [3 ]
O'Brien, Katie [3 ]
Mayanja, Billy N. [2 ]
White, Richard G. [3 ]
机构
[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 3P5, Canada
[2] Uganda Virus Res Inst, Med Res Council Unit AIDS, Entebbe, Uganda
[3] London Sch Hyg & Trop Med, London WC1, England
基金
英国医学研究理事会;
关键词
RURAL-POPULATION; INFECTION; TRANSMISSION; PREVENTION; RISK; INTERVENTIONS; PREVALENCE;
D O I
10.1136/sextrans-2013-051219
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. Methods A mathematical model, parameterised using site-specific data from Uganda and worldwide literature review, was used to examine the likely impact of ART on HIV epidemiologic trends. We varied assumptions about rates of initiating ART, and changes in sexual partner turnover rates. Results Modelling suggests that ART will reduce HIV incidence over 20 years, and increase prevalence. Even in the optimistic scenario of ART enrollment beginning after just five months of infection (in HIV stage 2), prevalence is estimated to rise from a baseline of 10.5% and 8.3% among women and men, respectively, to at least 12.1% and 10.2%, respectively. It will rise further if sexual disinhibition occurs or infectiousness while on ART is slightly higher (2% female to male, rather than 0.5%). The conditions required for ART to reduce prevalence over this period are likely too extreme to be achievable. For example, if ART enrolment begins in HIV stage 1 (within the first 5 months of infection), and if risky sexual behaviour does not increase, then 3 of our 11 top fitting results estimate a potential drop in HIV prevalence by 2025. If sexual risk taking rises, it will have a large additional impact on expected HIV prevalence. Prevalence will rise despite incidence falling, because ART extends life expectancy. Conclusions HIV prevalence will rise. Even small increases in partner turnover rates will lead to an additional substantial increase in HIV prevalence. Policy makers are urged to continue HIV prevention activities, including promoting sex education, and to be prepared for a higher than previously suggested number of HIV infected people in need of treatment.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [1] Depression and sexual risk behaviour among clients about to start HIV antiretroviral therapy in Uganda
    Musisi, Seggane
    Wagner, Glenn J.
    Ghosh-Dastidar, Bonnie
    Nakasujja, Noeline
    Dickens, Akena
    Okello, Elialilia
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (02) : 130 - 137
  • [2] Antiretroviral therapy and sexual behavior in Uganda: a cohort study
    Shafer, Leigh Anne
    Nsubuga, Rebecca N.
    White, Richard
    Mayanja, Billy N.
    Chapman, Ruth
    O'Brien, Katie
    Van der Paal, Lieve
    Grosskurth, Heiner
    Maher, Dermot
    AIDS, 2011, 25 (05) : 671 - 678
  • [3] ABC for people with HIV: responses to sexual behaviour recommendations among people receiving antiretroviral therapy in Jinja, Uganda
    Allen, Caroline
    Mbonye, Martin
    Seeley, Janet
    Birungi, Josephine
    Wolff, Brent
    Coutinho, Alex
    Jaffar, Shabbar
    CULTURE HEALTH & SEXUALITY, 2011, 13 (05) : 529 - 543
  • [4] HIV epidemiologic trends among occupational groups in Rakai, Uganda: A population-based longitudinal study, 1999-2016
    Popoola, Victor O.
    Kagaayi, Joseph
    Ssekasanvu, Joseph
    Ssekubugu, Robert
    Kigozi, Grace
    Ndyanabo, Anthony
    Nalugoda, Fred
    Chang, Larry W.
    Lutalo, Tom
    Tobian, Aaron A. R.
    Kabatesi, Donna
    Alamo, Stella
    Mills, Lisa A.
    Kigozi, Godfrey
    Wawer, Maria J.
    Santelli, John
    Gray, Ronald H.
    Reynolds, Steven J.
    Serwadda, David
    Lessler, Justin
    Grabowski, M. Kate
    PLOS GLOBAL PUBLIC HEALTH, 2024, 4 (02):
  • [5] Impact of HIV Antiretroviral Therapy on Depression and Mental Health Among Clients With HIV in Uganda
    Wagner, Glenn J.
    Ghosh-Dastidar, Bonnie
    Garnett, Jeffrey
    Kityo, Cissy
    Mugyenyi, Peter
    PSYCHOSOMATIC MEDICINE, 2012, 74 (09): : 883 - 890
  • [6] A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers
    McClelland, R. Scott
    Richardson, Barbra A.
    Cherutich, Peter
    Mandaliya, Kishorchandra
    John-Stewart, Grace
    Miregwa, Benard
    Odem-Davis, Katherine
    Jaoko, Walter
    Kimanga, Davies
    Overbaugh, Julie
    AIDS, 2015, 29 (17) : 2279 - 2286
  • [7] Impact of Antiretroviral Therapy on Adult HIV Prevalence in a Low-Income Rural Setting in Uganda: A Longitudinal Population-Based Study
    Nsubuga, Rebecca N.
    Maher, Dermot
    Todd, Jim E.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (05) : 562 - 568
  • [8] The impact of HIV antiretroviral treatment perception on risky sexual behaviour in Botswana: a short report
    Letamo, Gobopamang
    Keetile, Mpho
    Navaneetham, Kannan
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2017, 29 (12): : 1589 - 1593
  • [9] The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009
    Kasamba, Ivan
    Baisley, Kathy
    Mayanja, Billy N.
    Maher, Dermot
    Grosskurth, Heiner
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (08) : e66 - e73
  • [10] Sexual behaviour after antiretroviral therapy initiation in female sex workers and HIV-positive patients from the general population, Cotonou, Benin
    Diabate, Souleymane
    Chamberland, Annie
    Zannou, Djimon M.
    Geraldo, Nassirou
    Azon-Kouanou, Angele
    Massinga-Loembe, Marguerite
    Ahomadegbe, Christelle
    Labbe, Annie-Claude
    Tremblay, Cecile
    Alary, Michel
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2013, 25 (11): : 1426 - 1432